Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications characteristics influencing japanese atrial fibrillation patients preferences
… Collection of qualitative and quantitative data from patients, physicians, and other stakeholders Advice on …
… and cost-effectiveness of natalizumab and fingolimod in patients with inadequate response to disease-modifying …
… MSBase Registry: Comparing Natalizumab to Fingolimod in Patients with Inadequate Response to Disease-Modifying … MSBase Registry: Comparing Natalizumab to Fingolimod in Patients With Inadequate Response to Disease-Modifying … the clinical effectiveness of switching to natalizumab for patients with relapsing-remitting MS who are not responding …
… treatments have emerged as frontline therapies for patients diagnosed with chronic lymphocytic leukemia or … trends, we undertook a retrospective cohort study of CLL patients using a commercial claims database in the US. Our study includes nearly 1400 patients receiving their first treatment during July 2012 to …
… Therapeutic Experience Explore our Projects, Publications, and Researchers by Therapeutic Area To help you achieve your goal of treating and making your patients healthier, your research partner needs to have both …
… researchers across therapeutic fields to plan and develop publications highlighting their work. Key research fields and …
… is indicated in Europe to improve walking distances in patients with intermittent claudication. It has been … failed to improve symptoms. It was contraindicated in patients with unstable angina pectoris myocardial infarction … or coronary intervention within the last 6 months, or in patients with concomitant treatment with two or more …
… the inclusion of clinical data affect planned or pending publications? Manufacturers should determine the appropriate …
… Effective treatments can benefit caregivers as well as patients. However, inclusion of caregiver benefits into …
… disease burdens, unmet medical needs, and patient preferences. We support clinical trial design by …